Fund Initiates Cooper Companies Position Citing 65% CooperVision Revenue and Activist Catalyst
Mid Cap Strategy returned 3.2% (3.0% net) in Q4 2025 versus a 0.2% gain in the Russell Midcap Index, driven by stock selection and sector exposure. It initiated Cooper Companies, citing 65% revenue from CooperVision, a $16.612 billion market cap, margin expansion potential and activist catalyst.
1. Q4 2025 Strategy Performance
The strategy returned 3.2% (3.0% net) in Q4 2025, outpacing the Russell Midcap Index’s 0.2% gain and tracking above the Russell 3000’s 2.4% rise. Performance drivers included stock selection and sector allocation decisions.
2. Cooper Companies Initiation Rationale
The fund initiated a position in Cooper Companies, highlighting its two divisions: CooperVision, responsible for over 65% of revenue in a four-player oligopoly controlling 95% of the contact lens market, and CooperSurgical, which serves women’s healthcare.
3. Stock Performance and Valuation Metrics
Cooper Companies shares fell 8.17% over the past 52 weeks but climbed 3.83% over the last month. As of February 24, 2026, the company held a $16.612 billion market capitalization.
4. Catalyst and Outlook
Analysts flagged significant margin expansion potential as capital spending moderates and capacity utilization improves, and identified activist involvement as a catalyst for operational improvements and potential business separation.